FI932035A0 - Tricykliska foereningar innehaollande heteroatomer - Google Patents

Tricykliska foereningar innehaollande heteroatomer

Info

Publication number
FI932035A0
FI932035A0 FI932035A FI932035A FI932035A0 FI 932035 A0 FI932035 A0 FI 932035A0 FI 932035 A FI932035 A FI 932035A FI 932035 A FI932035 A FI 932035A FI 932035 A0 FI932035 A0 FI 932035A0
Authority
FI
Finland
Prior art keywords
heteroatomer
tricyclic
foereningar innehaollande
foereningar
innehaollande
Prior art date
Application number
FI932035A
Other languages
English (en)
Other versions
FI102612B1 (fi
FI102612B (fi
FI932035A (fi
Inventor
Karl Baumann
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929209815A external-priority patent/GB9209815D0/en
Priority claimed from GB939304927A external-priority patent/GB9304927D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of FI932035A0 publication Critical patent/FI932035A0/fi
Publication of FI932035A publication Critical patent/FI932035A/fi
Priority to FI982476A priority Critical patent/FI982476A0/fi
Application granted granted Critical
Publication of FI102612B1 publication Critical patent/FI102612B1/fi
Publication of FI102612B publication Critical patent/FI102612B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
FI932035A 1992-05-07 1993-05-05 Menetelmä terapeuttisesti käyttökelpoisten trisyklo£18.6.1.0 |heptako seenien ja niiden johdannaisten valmistamiseksi FI102612B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI982476A FI982476A0 (fi) 1992-05-07 1998-11-16 Heteroatomeja sisältäviä trisyklisiä yhdisteitä

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209815A GB9209815D0 (en) 1992-05-07 1992-05-07 Organic compounds,processes for their production and their use
GB939304927A GB9304927D0 (en) 1993-03-10 1993-03-10 Organic compounds

Publications (4)

Publication Number Publication Date
FI932035A0 true FI932035A0 (fi) 1993-05-05
FI932035A FI932035A (fi) 1993-11-08
FI102612B1 FI102612B1 (fi) 1999-01-15
FI102612B FI102612B (fi) 1999-01-15

Family

ID=26300836

Family Applications (2)

Application Number Title Priority Date Filing Date
FI932035A FI102612B (fi) 1992-05-07 1993-05-05 Menetelmä terapeuttisesti käyttökelpoisten trisyklo£18.6.1.0 |heptako seenien ja niiden johdannaisten valmistamiseksi
FI982476A FI982476A0 (fi) 1992-05-07 1998-11-16 Heteroatomeja sisältäviä trisyklisiä yhdisteitä

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI982476A FI982476A0 (fi) 1992-05-07 1998-11-16 Heteroatomeja sisältäviä trisyklisiä yhdisteitä

Country Status (25)

Country Link
US (1) US5514685A (fi)
EP (1) EP0569337B1 (fi)
JP (1) JP2788392B2 (fi)
KR (1) KR100292311B1 (fi)
CN (1) CN1037773C (fi)
AT (1) ATE155787T1 (fi)
AU (1) AU668152B2 (fi)
CA (1) CA2095659C (fi)
CY (1) CY2126B1 (fi)
CZ (1) CZ291773B6 (fi)
DE (1) DE69312386T2 (fi)
DK (1) DK0569337T3 (fi)
ES (1) ES2105193T3 (fi)
FI (2) FI102612B (fi)
GR (1) GR3024754T3 (fi)
HU (2) HUT66531A (fi)
IL (1) IL105607A (fi)
MY (1) MY109602A (fi)
NO (1) NO305865B1 (fi)
NZ (1) NZ247553A (fi)
PH (1) PH30456A (fi)
RU (1) RU2126009C1 (fi)
SG (1) SG47011A1 (fi)
SK (1) SK282061B6 (fi)
TW (1) TW330936B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY110603A (en) * 1993-05-27 1998-08-29 Novartis Ag Tetrahydropyran derivatives
IL115742A (en) 1994-10-26 2000-06-01 Novartis Ag Pharmaceutical compositions comprising a difficultly soluble active agent a hydrophilic phase a lipophilic phase and a surfactant
KR100434682B1 (ko) 1994-10-26 2004-08-18 노바티스 아게 약학조성물
RU2214244C9 (ru) 1998-03-26 2020-07-29 Астеллас Фарма Инк. Препараты с замедленным высвобождением
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
CA2492989C (en) 2002-07-23 2012-11-20 Novartis Ag Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
KR100469917B1 (ko) * 2002-09-09 2005-02-02 (주)조은식품 구수한 호박씨가 첨가된 호박엿 및 그 제조방법
KR100745493B1 (ko) * 2005-12-16 2007-08-03 주식회사농심 조직감이 향상된 사출 스낵 및 그 제조 방법
CN102958935B (zh) * 2010-04-02 2015-12-09 爱尔兰詹森科学公司 大环整合酶抑制剂
ES2898849T3 (es) 2014-10-28 2022-03-09 Koushi Yamaguchi Medicamento para mejorar el síndrome de hipertensión inducida por el embarazo
EP3834826A4 (en) 2018-08-10 2022-07-27 Koushi Yamaguchi THERAPEUTIC AGENT FOR HUMORAL IMMUNITY-RELATED DISEASES IN THE MATERNO-FETAL RELATIONSHIP
US20220062245A1 (en) 2018-12-18 2022-03-03 Koushi Yamaguchi Agent for improving infertility, recurrent miscarriage, and state of pregnancy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5254562A (en) * 1984-12-03 1993-10-19 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
EP0364031B1 (en) * 1988-10-12 1992-12-23 Merck & Co. Inc. Hydroxide mediated fk-506 rearrangement process
CA1316916C (en) * 1988-10-12 1993-04-27 David Askin Hydroxide mediated fk-506 rearrangement product
KR920700212A (ko) * 1989-06-14 1992-02-19 쟝 크라머·한스 루돌프 하우스 헤테로원자-함유 트리사이클릭 화합물
EP0413532A3 (en) * 1989-08-18 1991-05-15 Fisons Plc Macrocyclic compounds
IE904050A1 (en) * 1989-11-13 1991-05-22 Merck & Co Inc Aminomacrolides and derivatives having immunosuppressive¹activity
US5260301A (en) * 1990-03-01 1993-11-09 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical solution containing FK-506
GB2246350A (en) * 1990-07-23 1992-01-29 Fujisawa Pharmaceutical Co Tricyclo compounds
EP0480623A1 (en) * 1990-10-11 1992-04-15 Merck & Co. Inc. New halomacrolides and derivatives having immunosuppressive activity
WO1992013862A1 (en) * 1991-02-05 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Lactone compounds
JP3644957B2 (ja) * 1991-09-05 2005-05-11 アボット・ラボラトリーズ 大環式イムノモジュレーター

Also Published As

Publication number Publication date
NO305865B1 (no) 1999-08-09
EP0569337B1 (en) 1997-07-23
RU2126009C1 (ru) 1999-02-10
FI982476A0 (fi) 1998-11-16
HUT66531A (en) 1994-12-28
IL105607A (en) 1998-01-04
FI102612B1 (fi) 1999-01-15
NZ247553A (en) 1995-07-26
HU9301190D0 (en) 1993-07-28
DK0569337T3 (da) 1998-01-19
KR940005631A (ko) 1994-03-22
CN1083486A (zh) 1994-03-09
DE69312386T2 (de) 1998-01-29
SK43593A3 (en) 1995-07-11
NO931627L (no) 1993-11-08
CZ82993A3 (en) 1994-01-19
CY2126B1 (en) 2002-06-21
MY109602A (en) 1997-03-31
JPH0641144A (ja) 1994-02-15
CA2095659A1 (en) 1993-11-08
PH30456A (en) 1997-05-28
CA2095659C (en) 2005-08-09
KR100292311B1 (ko) 2001-09-17
FI102612B (fi) 1999-01-15
SK282061B6 (sk) 2001-10-08
SG47011A1 (en) 1998-03-20
HU211135A9 (en) 1995-10-30
EP0569337A1 (en) 1993-11-10
GR3024754T3 (en) 1997-12-31
NO931627D0 (no) 1993-05-05
AU668152B2 (en) 1996-04-26
DE69312386D1 (de) 1997-08-28
ATE155787T1 (de) 1997-08-15
IL105607A0 (en) 1993-09-22
US5514685A (en) 1996-05-07
TW330936B (en) 1998-05-01
CZ291773B6 (cs) 2003-05-14
JP2788392B2 (ja) 1998-08-20
ES2105193T3 (es) 1997-10-16
FI932035A (fi) 1993-11-08
AU3839393A (en) 1993-11-11
CN1037773C (zh) 1998-03-18

Similar Documents

Publication Publication Date Title
DE69319976D1 (de) 7-Substituierte-9-substituierte Glycylamido-6-Demethyl-6-Deoxytetracycline
ES2161220T3 (es) 9-((glicil sustituido)amido)-6-desmetil-6-desoxitetraciclinas como agentes antibioticos.
MX9304646A (es) Nuevas 7-(sustituido)-8-(sustituido)d-9-[(glicilo sustituido)amido]-6-desmetil-6-desoxitetraciclinasy metodo para su produccion.
ATE215530T1 (de) 7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel
ATE267164T1 (de) 9-(substituiertes glycyl)amido-6-(substituiert)-5-hydroxy-6-deoxy etracycline
NO962059L (no) Antiarytmiske benzodiazepiner
DK0671933T3 (da) Hidtil ukendte anvendelser af IL-10
FI932035A0 (fi) Tricykliska foereningar innehaollande heteroatomer
FI942444A (fi) Terahydropyraanijohdannaisia
DE69419661D1 (de) Thiazolotriazol- und Thiazolodiazolderivate mit fungizider Aktivität
DE69313931D1 (de) Polycyclische 31668P- und 31668U-Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als antibiotische oder antitumorale Arzneistoffe
NO305556B1 (no) Tiokarbamoylforbindelser og anvendelse derav samt middel for beskyttelse av tekniske materialer

Legal Events

Date Code Title Description
FG Patent granted

Owner name: NOVARTIS AG

GB Transfer or assigment of application

Owner name: NOVARTIS AG

MM Patent lapsed